Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125400121 | 12540012 | 1 | I | 20160602 | 20160706 | 20160708 | 20160708 | EXP | US-GLAXOSMITHKLINE-US2016GSK097116 | GLAXOSMITHKLINE | 69.00 | YR | F | Y | 83.20000 | KG | 20160708 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125400121 | 12540012 | 1 | PS | BUPROPION. | BUPROPION | 1 | Oral | UNK | 18644 | TABLET | |||||||||
| 125400121 | 12540012 | 2 | SS | SUTENT | SUNITINIB MALATE | 1 | Oral | 50 MG, CYC | Y | 0 | 50 | MG | |||||||
| 125400121 | 12540012 | 3 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | UNK | 0 | ||||||||||
| 125400121 | 12540012 | 4 | SS | AMLODIPINE BESILATE | AMLODIPINE BESYLATE | 1 | Oral | UNK | 0 | ||||||||||
| 125400121 | 12540012 | 5 | SS | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | Oral | UNK | 0 | ||||||||||
| 125400121 | 12540012 | 6 | SS | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | Oral | UNK | 0 | ||||||||||
| 125400121 | 12540012 | 7 | SS | PHENERGAN | PROMETHAZINE HYDROCHLORIDE | 1 | Oral | UNK | 0 | ||||||||||
| 125400121 | 12540012 | 8 | SS | XARELTO | RIVAROXABAN | 1 | Oral | UNK | 0 | ||||||||||
| 125400121 | 12540012 | 9 | SS | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | Oral | UNK | 0 | ||||||||||
| 125400121 | 12540012 | 10 | SS | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Oral | UNK | 0 | ||||||||||
| 125400121 | 12540012 | 11 | SS | RITALIN | METHYLPHENIDATE HYDROCHLORIDE | 1 | Oral | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125400121 | 12540012 | 1 | Depression |
| 125400121 | 12540012 | 2 | Salivary gland cancer |
| 125400121 | 12540012 | 3 | Hyperlipidaemia |
| 125400121 | 12540012 | 4 | Hypertension |
| 125400121 | 12540012 | 5 | Depression |
| 125400121 | 12540012 | 6 | Hypothyroidism |
| 125400121 | 12540012 | 7 | Nausea |
| 125400121 | 12540012 | 8 | Embolism |
| 125400121 | 12540012 | 9 | Depression |
| 125400121 | 12540012 | 10 | Nausea |
| 125400121 | 12540012 | 11 | Fatigue |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125400121 | 12540012 | HO |
| 125400121 | 12540012 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125400121 | 12540012 | Dyspnoea | |
| 125400121 | 12540012 | Mouth haemorrhage | |
| 125400121 | 12540012 | Palpitations | |
| 125400121 | 12540012 | Sinus bradycardia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125400121 | 12540012 | 1 | 20151001 | 0 | ||
| 125400121 | 12540012 | 2 | 20160411 | 20160602 | 0 | |
| 125400121 | 12540012 | 3 | 20130101 | 0 | ||
| 125400121 | 12540012 | 4 | 20120101 | 0 | ||
| 125400121 | 12540012 | 5 | 20150101 | 0 | ||
| 125400121 | 12540012 | 6 | 19900101 | 0 | ||
| 125400121 | 12540012 | 7 | 20160516 | 0 | ||
| 125400121 | 12540012 | 8 | 20160517 | 0 | ||
| 125400121 | 12540012 | 9 | 20150101 | 0 | ||
| 125400121 | 12540012 | 10 | 20160516 | 0 | ||
| 125400121 | 12540012 | 11 | 20160411 | 0 |